JSED2613th International CongressThe 13th International Congress of the Jordanian Society of Endocrinology, Diabetes and Metabolism
المؤتمر الدولي الثالث عشر للجمعية الأردنية لاختصاصيي الغدد الصم والسكري وأمراض الاستقلاب
- Wed–Fri, 18 – 20 November 2026
- Le Royal Hotel, Amman
- With the Hellenic Endocrine Society
Call for abstracts
Abstract submission
6 days left
Submission deadline
20 October 2026
Notification of acceptance
30 October 2026
Submit abstracts through the form on this page.
Abstracts submitted after the deadline will not be accepted.
Please follow the guidelines below carefully.
For questions, contact medical@jordan-valley.com.
Submission guidelines
- 1
Abstracts must be written in good English or Arabic and clearly show the content to be presented. Length should not exceed 250 words, in Times New Roman, size 12.
- 2
The title should be brief, describe the presentation, be written in capital letters and not exceed 20 words.
- 3
State the specific objectives of the study.
- 4
State the method used.
- 5
Summarize the results obtained and the conclusions reached.
- 6
Standard abbreviations can be used. Special or unusual abbreviations are not recommended; if necessary, place them in parentheses after the first appearance of the full word, except for unit symbols. Numerals rather than words may be used for numbers.
- 7
References are not required.
- 8
Authors’ names should be preceded by their initials. Please underline the presenting author.
- 9
The presenting author should register for the congress.
- 10
State institutional affiliations.
- 11
Include a correspondence address and the presenter’s name, together with the authors’ email, telephone and fax numbers.
- 12
Authors will be notified of acceptance and of the method of presentation.
Abstract body
Structure your abstract in these 4 parts. Every part is required.
- 01Background and aimsRequired
- 02MethodsRequired
- 03ResultsRequired
- 04ConclusionsRequired
Abstract categories
11 categories · choose one in the form- Diabetes: Epidemiology & Genetics
- Diabetes Therapeutics
- Diabetes Complications
- Pituitary Gland, Adrenal and Parathyroid Disorders
- Obesity
- Thyroid Disorders
- Endocrine Disorders in Pregnancy
- Pediatric Endocrinology
- Bone Health and Osteoporosis
- Continuous Glucose Monitoring
- Carb Counting and Insulin Dosing in Type 1 Diabetes


